{
    "paper_id": "a38684fb5a7630768dd579ba79c874db85b4479c",
    "metadata": {
        "title": "Mini-review Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/ pyrazolineethiazolidine-based hybrids",
        "authors": [
            {
                "first": "Dmytro",
                "middle": [],
                "last": "Havrylyuk",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Danylo Halytsky Lviv National Medical University",
                    "location": {
                        "addrLine": "69 Pekarska Street",
                        "postCode": "79010",
                        "settlement": "Lviv",
                        "country": "Ukraine"
                    }
                },
                "email": ""
            },
            {
                "first": "Olexandra",
                "middle": [],
                "last": "Roman",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Danylo Halytsky Lviv National Medical University",
                    "location": {
                        "addrLine": "69 Pekarska Street",
                        "postCode": "79010",
                        "settlement": "Lviv",
                        "country": "Ukraine"
                    }
                },
                "email": ""
            },
            {
                "first": "Roman",
                "middle": [],
                "last": "Lesyk",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Danylo Halytsky Lviv National Medical University",
                    "location": {
                        "addrLine": "69 Pekarska Street",
                        "postCode": "79010",
                        "settlement": "Lviv",
                        "country": "Ukraine"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "The features of the chemistry of 4-thiazolidinone and pyrazole/pyrazolines as pharmacologically attractive scaffolds were described in a number of reviews in which the main approaches to the synthesis of mentioned heterocycles and their biological activity were analyzed. However, the pyrazole/pyrazoline ethiazolidine-based hybrids as biologically active compounds is poorly discussed in the context of pharmacophore hybrid approach. Therefore, the purpose of this review is to summarize the data about the synthesis and modification of heterocyclic systems with thiazolidine and pyrazoline or pyrazole fragments in molecules as promising objects of modern bioorganic and medicinal chemistry. The description of biological activity was focused on SAR analysis and mechanistic insights of mentioned hybrids.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Pharmacophore hybrid approach is a current concept in drug design and development to produce molecules with improved affinity and efficacy. There are some reviews dealing with the concept of molecular hybridization and the promises/challenges associated with these hybrid molecules along with recent advances on anticancer hybrids [1e3] . Various heteroaryl based hybrids in particular isatin and coumarins [3] or indoline-thiazolidinones [4] have been recently reviewed as conjugates with remarkable inhibitory potential.",
            "cite_spans": [
                {
                    "start": 331,
                    "end": 336,
                    "text": "[1e3]",
                    "ref_id": null
                },
                {
                    "start": 407,
                    "end": 410,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 439,
                    "end": 442,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Design of new drug-like small molecules based on the pharmacologically attractive scaffolds of thiazolidine (4-thiazolidinone) [5e10] and pyrazole or pyrazoline [11e15] is a reasonable and promising direction in modern medicinal chemistry. The chemical approaches for the synthesis of thiazolidinone-and pyrazole-based derivatives and their pharmacological activity were described in a numerous reviews [5e12] . However, the pyrazole/pyrazolineethiazolidine-based conjugates as biologically active compounds are poorly reviewed in the context of pharmacophore hybrid approach.",
            "cite_spans": [
                {
                    "start": 108,
                    "end": 126,
                    "text": "(4-thiazolidinone)",
                    "ref_id": null
                },
                {
                    "start": 403,
                    "end": 409,
                    "text": "[5e12]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "The recent synthetic studies of pyrazoleethiazolidines and related hybrids and biological investigations for their antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory activities allowed to identify the promising drug-like compounds. Thus, the pyrazoleethiazolidinones/thiazoles have been patented as inhibitors of necroptosis [16] , VHR protein tyrosine phosphatase inhibitors [17] , Pin1-modulating compounds [18] , compounds for modulating RNA-binding proteins [19] and activators of proapoptotic BAX [20] . In addition, the pyrazoleethiazolidinone hybrids have been studied for their possibility to inhibit the TNF-aeTNFRc1 interaction [21] , as inhibitors of histone acetyltransferases [22] and inhibitors of COX [31, 39] and ADAMTS-5 enzymes [83] . Therefore, the purpose of this review is to summarize the data about the synthesis and biological activity of heterocyclic systems with thiazolidine and pyrazole/pyrazoline fragments in molecules. The most promising pyrazoleethiazolidinone/thiazole hybrids and target heterocycles that have been reviewed as fragments of hybrid molecules are depicted in Fig. 1 .",
            "cite_spans": [
                {
                    "start": 344,
                    "end": 348,
                    "text": "[16]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 395,
                    "end": 399,
                    "text": "[17]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 428,
                    "end": 432,
                    "text": "[18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 481,
                    "end": 485,
                    "text": "[19]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 521,
                    "end": 525,
                    "text": "[20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 657,
                    "end": 661,
                    "text": "[21]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 708,
                    "end": 712,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 735,
                    "end": 739,
                    "text": "[31,",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 740,
                    "end": 743,
                    "text": "39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 765,
                    "end": 769,
                    "text": "[83]",
                    "ref_id": "BIBREF82"
                }
            ],
            "ref_spans": [
                {
                    "start": 1126,
                    "end": 1132,
                    "text": "Fig. 1",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Introduction"
        },
        {
            "text": "The reviewed hybrids were classified as 2-, 3-and 5-pyrazole/ pyrazoline-substituted thiazolidines based on linkage of target heterocyclic cores. The basic approaches for the synthesis of mentioned derivatives provide a combination of two \"small\" molecules in aminolysis reactions, acylation and Knoevenagel procedure or heterocyclization of monocyclic compounds via the [2\u00fe3]cyclization reaction yielding the series of non-condensed bicyclic systems.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Detailed biological activity evaluation of pyrazolineethiazolidinone conjugates 1.2e1.7 and pyrazolineethiazoles 1.8, 1.9 (Fig. 2) , synthesized via the [2\u00fe3]cyclocondensation of 4,5-dihydropyrazole-1-carbothioamides 1.1 as S,N-binucleophiles in reactions with equivalents of dielectrophilic synthon [C2] 2\u00fe , allowed to identify compounds with antimicrobial [23e28], antiviral [29, 30] , anti-inflammatory [31] , antitumor [32e35] and insecticidal [36] activities. For synthesis of target derivatives a-halogenocarboxylic acids [31, 33] and their ethyl esters [23e29, 35, 36] , maleic anhydride [30] , maleimides [30, 38] , b-aroylacrylic acids [30] , dimethyl acetylenedicarboxylate [37] , bromoacetophenones [23, 24, 28, 29, 35] and ethyl 4chloroacetoacetate [35] were used as equivalents of dielectrophilic synthon [C2] 2\u00fe .",
            "cite_spans": [
                {
                    "start": 378,
                    "end": 382,
                    "text": "[29,",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 383,
                    "end": 386,
                    "text": "30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 407,
                    "end": 411,
                    "text": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 449,
                    "end": 453,
                    "text": "[36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 529,
                    "end": 533,
                    "text": "[31,",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 534,
                    "end": 537,
                    "text": "33]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 569,
                    "end": 572,
                    "text": "35,",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 573,
                    "end": 576,
                    "text": "36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 596,
                    "end": 600,
                    "text": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 614,
                    "end": 618,
                    "text": "[30,",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 619,
                    "end": 622,
                    "text": "38]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 646,
                    "end": 650,
                    "text": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 685,
                    "end": 689,
                    "text": "[37]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 711,
                    "end": 715,
                    "text": "[23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 716,
                    "end": 719,
                    "text": "24,",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 720,
                    "end": 723,
                    "text": "28,",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 724,
                    "end": 727,
                    "text": "29,",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 728,
                    "end": 731,
                    "text": "35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 762,
                    "end": 766,
                    "text": "[35]",
                    "ref_id": "BIBREF34"
                }
            ],
            "ref_spans": [
                {
                    "start": 122,
                    "end": 130,
                    "text": "(Fig. 2)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "Three-component one-pot reaction that includes [2\u00fe3]cyclocondensation of 4,5-dihydropyrazole-1-carbotioamides 1.1 with chloroacetic acid and the further Knoevenagel reaction with aromatic aldehydes [33, 34] and isatin derivatives [32] is an effective approach for design of new anticancer agents among the pyrazolineethiazolidinones 1.10, 1.11 (Fig. 3) .",
            "cite_spans": [
                {
                    "start": 198,
                    "end": 202,
                    "text": "[33,",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 203,
                    "end": 206,
                    "text": "34]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 230,
                    "end": 234,
                    "text": "[32]",
                    "ref_id": "BIBREF31"
                }
            ],
            "ref_spans": [
                {
                    "start": 344,
                    "end": 352,
                    "text": "(Fig. 3)",
                    "ref_id": null
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "The reaction between pyrazolyl-imines [39, 40] or pyrazolylhydrazones [41] and thioglycolic acid or its esters is widely used approach for the synthesis of 4-thiazolidinone conjugates 1.12, 1. VHR protein tyrosine phosphatase inhibitor [17] n = 3: Pin1-modulator [18] n = 5: HAT-inhibitor [22] RNA binding proteins modulator [19] Pro-apoptotic BAX activator [20] TNF-a inhibitor [21] with pyrazole moiety in position 2. A. Khodairy proposed a synthesis of 2-substituted 4-thiazolidinone with benzopyrano [2,3-c] pyrazol-3-one fragment 1.14, using N-cyanoacetyl-benzopyranopyrazolone [42] as a starting compound (Fig. 4) .",
            "cite_spans": [
                {
                    "start": 38,
                    "end": 42,
                    "text": "[39,",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 43,
                    "end": 46,
                    "text": "40]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 70,
                    "end": 74,
                    "text": "[41]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 236,
                    "end": 240,
                    "text": "[17]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 263,
                    "end": 267,
                    "text": "[18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 289,
                    "end": 293,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 325,
                    "end": 329,
                    "text": "[19]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 358,
                    "end": 362,
                    "text": "[20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 379,
                    "end": 383,
                    "text": "[21]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 504,
                    "end": 511,
                    "text": "[2,3-c]",
                    "ref_id": null
                },
                {
                    "start": 583,
                    "end": 587,
                    "text": "[42]",
                    "ref_id": "BIBREF41"
                }
            ],
            "ref_spans": [
                {
                    "start": 611,
                    "end": 619,
                    "text": "(Fig. 4)",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "Another direction for synthesis of pyrazole-substituted thiazoline 1.16 (Fig. 5) was realized by the creation of pyrazole moiety via the reaction between 5-fluoro-2-hydrazino-4-hydroxy-4,5bis(trifluoromethyl)-1,3-thiazoline 1.15 with acetoacetone [43, 44] .",
            "cite_spans": [
                {
                    "start": 247,
                    "end": 251,
                    "text": "[43,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 252,
                    "end": 255,
                    "text": "44]",
                    "ref_id": "BIBREF43"
                }
            ],
            "ref_spans": [
                {
                    "start": 72,
                    "end": 80,
                    "text": "(Fig. 5)",
                    "ref_id": null
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "A broad group of pyrazoleethiazolidinone derivatives exemplified by 2-imino-4-thiazolidinones (pseudothiohydantoines) 1.18, 1.19 were synthesized via [2\u00fe3]-cyclocondensation of pyrazole substituted asymmetric bis-thioureas 1.17 as S,N-binucleophiles with some equivalents of dielectrophilic synthon [C2] 2\u00fe (ethyl 2chloroacetate [45, 46] , dimethyl acetylenedicarboxylate [47] ). Simultaneously, bioisosteric pyrazolyl-2-iminothiazolidines 1.20 [46] were obtained by reaction of thioureas 1.17 with a-bromoacetophenones (Fig. 6 ).",
            "cite_spans": [
                {
                    "start": 329,
                    "end": 333,
                    "text": "[45,",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 334,
                    "end": 337,
                    "text": "46]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 372,
                    "end": 376,
                    "text": "[47]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 445,
                    "end": 449,
                    "text": "[46]",
                    "ref_id": "BIBREF45"
                }
            ],
            "ref_spans": [
                {
                    "start": 520,
                    "end": 527,
                    "text": "(Fig. 6",
                    "ref_id": null
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "Aiming to search for new anticancer or antimicrobial compounds among pyrazoleethiazolidinone conjugates the pyrazolesulfonyl-thioureas 1.21 were used as starting materials. The reaction between compounds 1.21 and ethyl 2-chloroacetate or abromoacetophenone resulted in formation of the corresponding pyrazoleethiazolidinones 1.22 and pyrazole-thiazolidines 1.23 with sulfonylimine linker group [48e53] (Fig. 7) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 402,
                    "end": 410,
                    "text": "(Fig. 7)",
                    "ref_id": null
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "Another approach for the synthesis of pyrazole derivatives of pseudothiohydantoin 1.26 was suggested by B. Insuasty et al. [54] . The synthesis of target compounds was carried out via aminolysis of 5-arylidene-2-thioxo-4-thiazolidinones (5-arylidenerhodanines) 1.24 by 4,5-diaminopyrazoles 1.25 (Fig. 8) .",
            "cite_spans": [
                {
                    "start": 123,
                    "end": 127,
                    "text": "[54]",
                    "ref_id": "BIBREF53"
                }
            ],
            "ref_spans": [
                {
                    "start": 295,
                    "end": 303,
                    "text": "(Fig. 8)",
                    "ref_id": null
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "A row of 2-pyrazolyl-hydrazoneethiazolidinones 1.28e1.30 was synthesized via [2\u00fe3]-cyclocondensation of thiosemicarbazones 1.27 with a-halogenocarboxylic acids derivatives or maleic anhydride [55e60]. The pyrazole with bioisosteric 2-thiohydantoin 1.31 [61] and thiazolidine 1.32 [55e60] fragments were obtained by reaction of thiosemicarbazones 1.27 with chloroacetic acid in pyridine or a-bromoacetophenone. However, the reaction of thiosemicarbazones 1.27 with acetic anhydride or iron chloride was accompanied by the formation of pyrazoleethiadiazole derivatives 1.33, 1.34 [56] (Fig. 9 ).",
            "cite_spans": [
                {
                    "start": 253,
                    "end": 257,
                    "text": "[61]",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 578,
                    "end": 582,
                    "text": "[56]",
                    "ref_id": "BIBREF55"
                }
            ],
            "ref_spans": [
                {
                    "start": 583,
                    "end": 590,
                    "text": "(Fig. 9",
                    "ref_id": "FIGREF6"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "Pyrazole-substituted thiosemicarbazides 1.35 were used for synthesis of the pyrazoleethiazolidinones 1.36 with carbohydrazide linker group [62, 63] . The three-component one-pot reaction between thiosemicarbazides 1.35, chloroacetic acid and aromatic aldehydes accompanied by formation of the corresponding 5-arylidene-4-thiazolidinones 1.37 [63, 64] . The modification of 1.35 in sulfuric acid medium gave pyrazoleethiadiazole 1.38 [64] . The reaction of compounds 1.35 with a-bromoacetophenones was accompanied by the formation of corresponding pyrazole-thiazolidine conjugates 1.39 [62e64] (Fig. 10 ).",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 143,
                    "text": "[62,",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 144,
                    "end": 147,
                    "text": "63]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 342,
                    "end": 346,
                    "text": "[63,",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 347,
                    "end": 350,
                    "text": "64]",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 433,
                    "end": 437,
                    "text": "[64]",
                    "ref_id": "BIBREF63"
                }
            ],
            "ref_spans": [
                {
                    "start": 593,
                    "end": 601,
                    "text": "(Fig. 10",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2"
        },
        {
            "text": "Synthesis of 2-diazole-substituted 4-thiazolidinones was achieved via the [2\u00fe3]-cyclocondensation of the pyrazole-based asymmetric thioureas 1.17 as S,N-binucleophiles (see Fig. 6 ). At the same time, the numerous papers represent the data about obtaining of 4-thiazolidinones with diazole moiety in 3 position (compound 2.1, Fig. 11 ), in particular via the reaction of thioureas with ethylchloroacetate [65] .",
            "cite_spans": [
                {
                    "start": 405,
                    "end": 409,
                    "text": "[65]",
                    "ref_id": "BIBREF64"
                }
            ],
            "ref_spans": [
                {
                    "start": 173,
                    "end": 179,
                    "text": "Fig. 6",
                    "ref_id": null
                },
                {
                    "start": 326,
                    "end": 333,
                    "text": "Fig. 11",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "The dithiocarbamate method of 2-thioxo-4-thiazolidinones (rhodanines) synthesis is a convenient and often used variant of the synthesis of 4-thiazolidinone derivatives based on the [2\u00fe3]cyclocondensation [5] . R.M. Mohareb et al. had successfully applied the dithiocarbamate method for the synthesis of 3-(pyrazol-5-yl)-2-thioxo-4-thiazolidinone via two-stage process based on the reaction between 3-phenyl-5-aminopyrazole 2.2 and carbon disulfide in an alkaline medium and subsequent cyclization with Various 4-thiazolidinones were synthesized by reaction of amercaptocarboxylic acids (especially thioglycolic acid) with isothiocyanates (ReN]C]S). Thus, a pyrazoleethiazolidinone 2.8 with phenyl sulfonamide linker group was obtained based on the mentioned approach [67] . There were described the synthesis of 3pyrazole-substituted or polyheterocyclic derivatives of 4thiazolidinones 2.9, 2.10 based on the reaction between thioglycolic acid and corresponding imines and methylidenehydrazydes or three-component reaction involving thioglycolic acid, aromatic aldehydes and heterocyclic amines containing diazole fragment [68e72]. The reaction of isatin with heterocyclic amines led to Schiff's bases which were further reacted with thioglycolic acid to form 3-diazole-substituted indoline-spirothiazolidinones 2.11 [73, 74] (Fig. 13 ).",
            "cite_spans": [
                {
                    "start": 204,
                    "end": 207,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 767,
                    "end": 771,
                    "text": "[67]",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 1317,
                    "end": 1321,
                    "text": "[73,",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1322,
                    "end": 1325,
                    "text": "74]",
                    "ref_id": "BIBREF73"
                }
            ],
            "ref_spans": [
                {
                    "start": 1326,
                    "end": 1334,
                    "text": "(Fig. 13",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "The reaction between trithiocarbonyl diglycolic acid and amines in alcohol or alcoholewater medium (Holmberg synthesis) is a convenient and effective method for synthesis of 3-substituted rhodanines, especially based on the aromatic amines and carboxylic acid hydrazides [5] . The mentioned reaction was used by Augustin M. et al. for synthesis of rhodanine 2.12 with benzopyrazole fragment in position 3 [75] (Fig. 14) . The method for synthesis of pyrazoleethiazolidinone 2.15 ( Fig. 15 ) with acetamide linker group was proposed based on the reaction of 5-arylidenerhodanine-3-acetic acid 2.13 and 5aminopyrazole 2.14 in DMF in the presence of HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3oxid hexafluorophosphate) [76] .",
            "cite_spans": [
                {
                    "start": 271,
                    "end": 274,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 405,
                    "end": 409,
                    "text": "[75]",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 747,
                    "end": 751,
                    "text": "[76]",
                    "ref_id": "BIBREF75"
                }
            ],
            "ref_spans": [
                {
                    "start": 410,
                    "end": 419,
                    "text": "(Fig. 14)",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 481,
                    "end": 488,
                    "text": "Fig. 15",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "Synthesis of structurally related azolidineepyrazolines 2.16, 2.17 was proposed based on N-alkylation reaction of potassium salts of 2,4-thiazolidinedione, hydantoin and their 5-arylidene derivatives, obtained in situ (Fig. 16 ). 2-Chloro-1-(3,5-diarylpyrazolin-1-yl)ethanones were successfully used as alkylating agents [77] . successfully modified in diazo coupling reaction [91] using pyrazolyl diazonium chloride yielding compound 3.3 (Fig. 17) .",
            "cite_spans": [
                {
                    "start": 321,
                    "end": 325,
                    "text": "[77]",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 377,
                    "end": 381,
                    "text": "[91]",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 218,
                    "end": 226,
                    "text": "(Fig. 16",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 439,
                    "end": 448,
                    "text": "(Fig. 17)",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "The synthesis of pyrazolineeindolineethiazolidinone conjugates 3.5, 3.6 was realized by the Knoevenagel reaction of pyrazolineeisatines 3.4 with 2,4-thiazolidinedione, 2-thioxo-4thiazolidinone and 2-amino-4-thiazolidinone in the acetic acid medium and in the presence of sodium acetate [92] (Fig. 18 ).",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 290,
                    "text": "[92]",
                    "ref_id": "BIBREF91"
                }
            ],
            "ref_spans": [
                {
                    "start": 291,
                    "end": 299,
                    "text": "(Fig. 18",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "The synthesis of pyrazoloneethiazolidinones 3.7 ( Fig. 19 ) was achieved based on the reaction between isonitrosorhodanines and 5-methyl-2,4-dihydropyrazol-3-one using piperidine as basic catalyst [93] .",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 201,
                    "text": "[93]",
                    "ref_id": "BIBREF92"
                }
            ],
            "ref_spans": [
                {
                    "start": 50,
                    "end": 57,
                    "text": "Fig. 19",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "Magdy allowed to obtain the corresponding pyrazole-thiazolidinones 3.9 [94] . Using hydrazine hydrate the structure of final compounds depended on the reaction medium. Thus, 1N-non-substituted pyrazoles were obtained in alcohol medium and in the presence of sodium ethylate, while 1N-acetylderivatives were formed in acetic acid. The reaction of the compound 3.8 and 1-phenylpyrazolidin- 3,5-dione in the presence of sodium ethylate led to formation of polyheterocyclic system 3.10 (Fig. 20) .",
            "cite_spans": [
                {
                    "start": 71,
                    "end": 75,
                    "text": "[94]",
                    "ref_id": "BIBREF93"
                }
            ],
            "ref_spans": [
                {
                    "start": 482,
                    "end": 491,
                    "text": "(Fig. 20)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "Synthesis of 5-pyrazolyl-4-thiazolidinones with ethylene linker group 3.11 was performed via the [2\u00fe3]-cyclocondensation reaction of thiourea with g-pyrazolyl-a-chlorobutanoates [95] (see Pharmacologically attractive 5-(5-oxo-4,5-dihydro-1H-pyrazol-4-yl)rhodanines 3.12 ( Fig. 22 ) were synthesized following heterocyclization of 2-thiazolidinyl-3-oxobutanoates with phenylhydrazine or conjugation of 4-bromopyrazolon-5-ones to 3arylrhodanines [96] .",
            "cite_spans": [
                {
                    "start": 178,
                    "end": 182,
                    "text": "[95]",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 444,
                    "end": 448,
                    "text": "[96]",
                    "ref_id": "BIBREF95"
                }
            ],
            "ref_spans": [
                {
                    "start": 272,
                    "end": 279,
                    "text": "Fig. 22",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "The group of pyrazolineethiazolidinones 3.13 was obtained by reaction of 5-bromo-2,4-thiazolidindione with 3,5diarylpyrazolines in alcohol medium (Fig. 23 ). The synthesized compounds were modified in position 3 of thiazolidine cycle by Mannich reaction with secondary cyclic amines and alkylation reactions forming 3.14, 3.15 [97] .",
            "cite_spans": [
                {
                    "start": 327,
                    "end": 331,
                    "text": "[97]",
                    "ref_id": "BIBREF96"
                }
            ],
            "ref_spans": [
                {
                    "start": 146,
                    "end": 154,
                    "text": "(Fig. 23",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "The following approach to the synthesis of pyrazolineethiazolidinone conjugates 3.16 with carbonyl methylidene linker group was based on the acylation reaction of 3,5diarylpyrazolines (Fig. 24) . The further reaction of substances 3.16 with chloroacetamides via N-alkylation reaction led to derivatives 3.17 [97] .",
            "cite_spans": [
                {
                    "start": 308,
                    "end": 312,
                    "text": "[97]",
                    "ref_id": "BIBREF96"
                }
            ],
            "ref_spans": [
                {
                    "start": 184,
                    "end": 193,
                    "text": "(Fig. 24)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "To explore the structure-antitrypanosomal activity relationship the pyrazolineethiazolidinone conjugates 3.18 were synthesized through the reaction of the 5-ethoxymethylidenerhodanines with 3,5-diarylpyrazolines (Fig. 25 ). 5-Pyrazoline substituted 4-thioxo-2-thiazolidinones 3.19 were obtained under the same conditions [98] .",
            "cite_spans": [
                {
                    "start": 321,
                    "end": 325,
                    "text": "[98]",
                    "ref_id": "BIBREF97"
                }
            ],
            "ref_spans": [
                {
                    "start": 212,
                    "end": 220,
                    "text": "(Fig. 25",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "To continue the above mentioned study, 5-pyrazoline derivatives of 4-thiazolidinone 3.21 with oxoethylamino-methylene linker group were synthesized by modification of rhodanine-5carboxylic acid 3.20 in the reaction with pyrazolines and in the presence of DCC (dicyclohexylcarbodiimide) [98] (Fig. 26 ).",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 290,
                    "text": "[98]",
                    "ref_id": "BIBREF97"
                }
            ],
            "ref_spans": [
                {
                    "start": 291,
                    "end": 299,
                    "text": "(Fig. 26",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3"
        },
        {
            "text": "Antitumor activity evaluation is promising for the thiazolidinones with pyrazoline fragment. The in vitro anticancer activity of thiazolidinones with pyrazoline cycle in position 2 (4.2) or 4 (4.3) of thiazolidine was tested by the National Cancer Institute (NCI) and most of them displayed anticancer activity on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate and breast cancers cell lines. The most efficient anticancer compound 4.1 was found to be active with selective influence on colon cancer cell lines, especially on HT 29 (lgGI 50 \u00bc \u00c06.37) [33] . The SAR study revealed that: (1) anticancer activity of compounds is sensitive to the nature of substituent in position 5 of thiazolone cycle, (2) introduction of p-OH group in 5-benzylidene fragment enhanced potency, and (3) the positional isomers, namely 2-pyrazoline (4.2) and 4-pyrazoline (4.3) substituted thiazolones are promising compounds for further optimization (Fig. 27) .",
            "cite_spans": [
                {
                    "start": 565,
                    "end": 569,
                    "text": "[33]",
                    "ref_id": "BIBREF32"
                }
            ],
            "ref_spans": [
                {
                    "start": 944,
                    "end": 953,
                    "text": "(Fig. 27)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "Novel pyrazolineethiazolidinoneeisatin 4.4 and pyrazoleindoline-2-one 4.5 conjugates were designed as potential anticancer agents (Fig. 28) . The most effective anticancer compound 4.6 was found to be active with a mean GI 50 (2) attachment of halogen (Br or Cl) to 5-position of isatin scaffold allowed to gain one log unit of activity (GI 50 level), in comparison with 5-unsubstituted isatin analogs; (3) introduction of a methyl group or CH 2 COOH group at 1N-position of isatin fragment led to the loss of activity; (4) the nature of a substituent in the 5-aryl fragment also had an influence on the antitumor activity. Therefore, the introduction of electron-withdrawing group e 4chlorine improved the antiproliferative activity in comparison with electron-donor 2-OH, 4-OMe and 4-NMe 2 groups. This would indicate that decreased of electron density on 5-aryl moiety is important for the inhibitory activity; and (5) substitution of the phenyl fragment in 3 position of pyrazoline cycle on naphthalene-2-yl substituent did not have significant influence on antitumor activity, but introduction of the 4-methoxyphenyl group in the mentioned position limited this effect [32] . method. As a result of studies two hit-compounds 4.10 and 4.11 were selected. SAR analysis showed that the determining factor for expression of antitumor activity is the structure of the substituent in the 4 position of thiazole (Fig. 29) . A modification of the ester group into hydrazide and, subsequently, a hydrazone gave the potentiation of antitumor properties. At the same time, pyrazolineethiazolidinones 4.9 had no significant cytotoxicity [35] .",
            "cite_spans": [
                {
                    "start": 223,
                    "end": 225,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 1174,
                    "end": 1178,
                    "text": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 1630,
                    "end": 1634,
                    "text": "[35]",
                    "ref_id": "BIBREF34"
                }
            ],
            "ref_spans": [
                {
                    "start": 130,
                    "end": 139,
                    "text": "(Fig. 28)",
                    "ref_id": "FIGREF3"
                },
                {
                    "start": 1410,
                    "end": 1419,
                    "text": "(Fig. 29)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "The series of pyrazolineethiazolidine-based compounds were tested for antitumor activity according to standard NCI protocol and 4-thiazolidinone derivatives with pyrazoline fragment 4.12, 4.14, 4.17 showed moderate cytostatic effect. The group of publications includes the synthesis of these pyrazolineethiazolidinones 4.12, 4.14, 4.17 and pyrazolineethiazolidines 4.13, 4.15, 4.16, 4.18 with diversity of substitution in pyrazole core. The analysis of mentioned results demonstrates that the modification of pyrazoline fragment is not crucial to the implementation of antineoplastic action (Fig. 30) . This statement is evidenced by the level of efficiency of compounds 4.12e4.18 with moderate rates of effective Magdy I. El-Zahar et al. [55] synthesized a group of benzofuranepyrazoles with various heterocycles, including thiazole (4.19) and thiazolidine (4.20) fragments for screening of antitumor activity on lines: HEPG2 (liver carcinoma cell line) and HELA (cervix carcinoma cell line). Interestingly, each of these compounds showed selective effect on one of the lines similar to 5-fluorouracil (Fig. 31) .",
            "cite_spans": [
                {
                    "start": 739,
                    "end": 743,
                    "text": "[55]",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 834,
                    "end": 840,
                    "text": "(4.19)",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 591,
                    "end": 600,
                    "text": "(Fig. 30)",
                    "ref_id": null
                },
                {
                    "start": 1103,
                    "end": 1112,
                    "text": "(Fig. 31)",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "Synthesis and study of antitumor activity of pyrazole-thiazolidinoneetriazoles on lung cancer MCF-7 line were conducted by Arun M. Isloor et al. [40] . Among the studied conjugates the compound 4.21 was the most active with the effective concentration IC 50 \u00bc 22 mg/mL. The presence of o-tolyl fragment was most favorable for the anticancer effect, while substitution with naphthyl ring caused complete loss of activity (Fig. 32 ).",
            "cite_spans": [
                {
                    "start": 145,
                    "end": 149,
                    "text": "[40]",
                    "ref_id": "BIBREF39"
                }
            ],
            "ref_spans": [
                {
                    "start": 420,
                    "end": 428,
                    "text": "(Fig. 32",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "An important achievement in the study of anticancer pyrazolethiazolidinone hybrid compounds is the establishing of the necroptosis inhibition for pseudothiohydantoin derivatives with pyrazole moiety in 5 position (Fig. 33) . Among these derivatives a potential inhibitor Necrostatin-7 (Nec-7) was identified with the , phenol (4.23) and phenyl sulphanilic (4.24) fragments allowed to get 3e7 fold potentiation in comparison to Nec-7. In general, it should be noted that the presence of the substituent in the 4 position and its nature was crucial for the implementation of necroptosis inhibitory activity, because the change of a fluorine atom position was accompanied by loss of activity. The authors synthesized a group of related compounds with aromatic heterocycles (triazole and isooxazole) to establish the impact of pyrazole cycle for activity. This modification resulted in the loss of inhibitory activity, which confirmed the importance of pyrazole moiety in the analogs Nec-7 [87] . The study of antitumor activity for pyrazole-rhodanines allowed to identify the compound 4.25, which proved effective inhibitory effect on the most of the 60 tumor lines at micromolar concentrations according to NCI protocol (Fig. 34) . The substance 4.25 was characterized by a selective effect on leukemia and lung cancer cell lines e especially on HOP-92 (lung cancer) with the values of effective concentration and cytotoxicity GI 50 \u00bc 0.62 mM and LC 50 > 100 mM, respectively [82] .",
            "cite_spans": [
                {
                    "start": 986,
                    "end": 990,
                    "text": "[87]",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 1474,
                    "end": 1478,
                    "text": "[82]",
                    "ref_id": "BIBREF81"
                }
            ],
            "ref_spans": [
                {
                    "start": 213,
                    "end": 222,
                    "text": "(Fig. 33)",
                    "ref_id": null
                },
                {
                    "start": 1218,
                    "end": 1227,
                    "text": "(Fig. 34)",
                    "ref_id": "FIGREF2"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "Manal Sarkis et al. carried out the synthesis of new bisthiazolone derivatives as potential inhibitors of CDC25V phosphatase (specified enzyme involved in cell cycle progression and unregulated tumor development). Aiming to investigate the selectivity, the affinity of the compounds was studied to PTP1B (Protein Tyrosine Phosphatase 1B) and VHR (Vaccinia virus H1 Related e a dual-specificity phosphatase). Overall 31 compounds from bis-thiazolidinone group were synthesized and most of them displayed inhibitory activity with micromolar IC 50 values lower than the corresponding monomers. Mentioned group of the compounds included the thiazolidinoneeindazole conjugate 4.26 (Fig. 35) . It was established that the replacement of a 4hydroxyphenyl fragment with indazole was accompanied by selective inhibition of CDC25B phosphatase and loss of PTP1B inhibitory activity (abolished PTP1B inhibition) [99] .",
            "cite_spans": [
                {
                    "start": 900,
                    "end": 904,
                    "text": "[99]",
                    "ref_id": "BIBREF98"
                }
            ],
            "ref_spans": [
                {
                    "start": 676,
                    "end": 685,
                    "text": "(Fig. 35)",
                    "ref_id": null
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "Screening of in vitro antitumor activity for 5-pyrazoline showed that the introduction of the linker group between heterocycles promoted the potentiation of antitumor activity, however, modification of 3N-position of thiazolidinone cycle via Mannich reaction and alkylation was not effective approach to optimization of hit-compounds (Fig. 36 ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 334,
                    "end": 342,
                    "text": "(Fig. 36",
                    "ref_id": null
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids"
        },
        {
            "text": "The search for new antimicrobial and antifungal agents among pyrazolineethiazolidinone related conjugates is a promising direction for biological testing of mentioned compounds. Mervat M. El-Enany et al. synthesized the group of 4-thiazolidinones and thiazoles with pyrazoline fragment in 2 position and studied their antimicrobial activity against Gram-positive (Staphylococcus aureus, Bacillus subtilis), gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and fungi Candida albicans [24] . However, the compound 4.31 was inactive to any of the microorganisms, while activity of 4.32 on B. subtilis appeared commensurate with Amoxacillin and Propenicillin (Fig. 37) . The research of Bakr F. of microorganisms with MIC values range \u00bc 50e500 mg/mL [25] .",
            "cite_spans": [
                {
                    "start": 500,
                    "end": 504,
                    "text": "[24]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 763,
                    "end": 767,
                    "text": "[25]",
                    "ref_id": "BIBREF24"
                }
            ],
            "ref_spans": [
                {
                    "start": 672,
                    "end": 681,
                    "text": "(Fig. 37)",
                    "ref_id": null
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "However, among the above groups of compounds 4.38 could be selected, which showed 2e8 times higher bactericidal activity in experiment than Ampicillin and was twice active than Griseofulvin on fungi. The mentioned compound showed the highest activity with the value of MIC 12.5 mg/mL to P. aeruginosa (Fig. 37) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 301,
                    "end": 310,
                    "text": "(Fig. 37)",
                    "ref_id": null
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "C.S. Reddy et al. performed the synthesis and study of antimicrobial activity of thiazolidinoneepyrazoles 4.39 against the B. subtilis, S. aureus, E. coli and S. pyogenes. It was established the moderate effect of mentioned compounds (MIC \u00bc 6.25e50 mg/mL) (Fig. 38) . The introduction of chlorine, nitro or hydroxyl groups in the para-position of the benzene ring resulted in 2e4 fold potentiation of activity in comparison to 3-phenyl-4-thiazolidinones. However, replacement of the phenyl moiety to pyridine (4.40) or pyrimidine was particularly effective, which allowed to get 4e8 fold enhance of efficiency [100] .",
            "cite_spans": [
                {
                    "start": 610,
                    "end": 615,
                    "text": "[100]",
                    "ref_id": "BIBREF99"
                }
            ],
            "ref_spans": [
                {
                    "start": 256,
                    "end": 265,
                    "text": "(Fig. 38)",
                    "ref_id": null
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "The pyrazoleethiazolidinones 4.41 or pyrazoleethiazoles 4.42, coupled by hydrazone linker group were investigated as promising agents with antimicrobial and antifungal activity. It was found that the compound 4.41b (R \u00bc Me) showed comparable activity (MIC \u00bc 25 mg/mL) with Ampicillin against E. coli, and the compound 4.41c (R \u00bc Cl) appeared to be the most active on C. albicans (MIC \u00bc 12.5 mg/mL) (Fig. 39) . Overall, pyrazole-thiazolidinones 4.41 had higher activity than related pyrazole-thiazoles 4.42 [60] . was effective bactericidal agent on the strain S. aureus (MIC \u00bc 20.8 mg/mL) and showed significant antifungal effect on S. cervesia (MIC \u00bc 41.6 mg/mL) [58] .",
            "cite_spans": [
                {
                    "start": 506,
                    "end": 510,
                    "text": "[60]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 664,
                    "end": 668,
                    "text": "[58]",
                    "ref_id": "BIBREF57"
                }
            ],
            "ref_spans": [
                {
                    "start": 398,
                    "end": 407,
                    "text": "(Fig. 39)",
                    "ref_id": "FIGREF6"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "Evaluation of antimicrobial activity for thiazolidines with 5pyrazolone fragment 4.51e4.53 (Fig. 41) revealed their effectiveness on B. subtilis NCTC 10400, S. aureus ATCC 25923, E. coli ATCC 25922, P. aeruginosa ATCC 10415) and fungi C. albicans TMRU 3669, A. niger ATCC 6265 [57] .",
            "cite_spans": [
                {
                    "start": 277,
                    "end": 281,
                    "text": "[57]",
                    "ref_id": "BIBREF56"
                }
            ],
            "ref_spans": [
                {
                    "start": 91,
                    "end": 100,
                    "text": "(Fig. 41)",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "An antimicrobial screening was carried out for 3-pyrazolinyl-4thiazolidinones against gram-positive bacteria S. aureus MTCC096, B. subtilis MTCC 441 and Staphylococcus epidermis MTCC435, gramnegative bacteria E. coli MTCC 443, P. aeruginosa MTCC 424, S. typhi MTCC 733 and K. pneumoniae MTCC 432, and antifungal effect was studied on A. niger MTCC 282, Aspergillus fumigatus MTCC 343, Aspergillus flavus MTCC 277 and C. albicans MTCC 227. In general the tested compounds (Fig. 42) showed promising antimicrobial activity. However, it could be emphasized that the bis-spiroindolones 4.55 showed better growth inhibition compared with compounds 4.54 [101] .",
            "cite_spans": [
                {
                    "start": 648,
                    "end": 653,
                    "text": "[101]",
                    "ref_id": "BIBREF100"
                }
            ],
            "ref_spans": [
                {
                    "start": 471,
                    "end": 480,
                    "text": "(Fig. 42)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "S.S. Reddy et al. proposed the synthesis of pyrazole-pyrimidineethiazolidinones 4.56 (Fig. 43 ) and the study of their The compounds with furane and 4-dimethylaminophenyl-groups in position 2 of thiazolidinone showed a higher or comparable efficacy (MIC \u00bc 14e22 mg/mL) to Fluconazole [72] .",
            "cite_spans": [
                {
                    "start": 284,
                    "end": 288,
                    "text": "[72]",
                    "ref_id": "BIBREF71"
                }
            ],
            "ref_spans": [
                {
                    "start": 85,
                    "end": 93,
                    "text": "(Fig. 43",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "Among 5-pyrazolyl-4-thiazolidinones the compounds 4.57 (Fig. 44) were investigated for their antimicrobial activity. The most effective pyrazole-thiazolidinones included the 4-Br-phenyl or thiophene fragments in molecules and showed 2e4 times higher efficiency (MIC \u00bc 16e31 mg/mL) in comparison with other derivatives [80] . The moderate antimicrobial activity towards E. coli and S. aureus was identified for 3N-glycoside substituted 2-thioxo- 4-thiazolidinone derivatives 4.58 (Fig. 44 ). The p-bromophenyl substituted derivative showed the highest efficiency against E. coli (MIC \u00bc 143 mg/mL) but was 3 times less active than tetracycline (MIC \u00bc 39 mg/mL) [84] .",
            "cite_spans": [
                {
                    "start": 318,
                    "end": 322,
                    "text": "[80]",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 659,
                    "end": 663,
                    "text": "[84]",
                    "ref_id": "BIBREF83"
                }
            ],
            "ref_spans": [
                {
                    "start": 55,
                    "end": 64,
                    "text": "(Fig. 44)",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 479,
                    "end": 487,
                    "text": "(Fig. 44",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "However, the most promising group of antimicrobial agents is 5pyrazolylrhodanines 4.59e4.63 [85, 86, 102, 103] . Antimicrobial activity of these substances was studied against methicillin-(MRSA) and quinolone-resistant (QRSA) S. aureus. Compounds 4.59e4.61 exhibited stronger activity than the standard drugs, norfloxacin and oxacillin, with MIC values of 1e2 mg/mL. SAR analysis for pyrazolerhodanine derivatives 4.62, 4.63 revealed the importance of aryl moiety presence in the pyrazole ring for expression of antimicrobial action and a number of substituents that considerably increased effectiveness were identified (Fig. 45 ).",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 96,
                    "text": "[85,",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 97,
                    "end": 100,
                    "text": "86,",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 101,
                    "end": 105,
                    "text": "102,",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 106,
                    "end": 110,
                    "text": "103]",
                    "ref_id": "BIBREF102"
                }
            ],
            "ref_spans": [
                {
                    "start": 620,
                    "end": 628,
                    "text": "(Fig. 45",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazolineethiazolidinones"
        },
        {
            "text": "The search for new chemotherapeutic agents among pyrazoleethiazolidinones is not limited by anticancer and antimicrobial studies. The evaluation of antiviral and antiparasitic activities for mentioned hybrid compounds allowed identifying promising hit-compounds and conducting SAR analysis. Osama I. El-Sabbagh proposed the synthesis of a group of pyrazolineethiazolidinones 4.64 and structurally related pyrazolineethiazoles 4.65 (Fig. 46) and performed a study of a wide range of antiviral activity. It should be noted that described compounds showed selective activity. However, one derivative (Ar \u00bc 4-Me-C 6 H 4 ) among compounds 4.64 had moderate efficacy against herpes simplex virus type 1, herpes simplex virus type 2, vaccinia virus, vesicular stomatitis virus and thymidine kinase-deficient herpes simplex virus type 1 with value of the effective concentration of 4 mg/mL and cytotoxicity value 20 mg/ mL (SI \u00bc 5) [29] .",
            "cite_spans": [
                {
                    "start": 924,
                    "end": 928,
                    "text": "[29]",
                    "ref_id": "BIBREF28"
                }
            ],
            "ref_spans": [
                {
                    "start": 431,
                    "end": 440,
                    "text": "(Fig. 46)",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazoleethiazolidinone hybrids"
        },
        {
            "text": "Study of thiazolidinones with sulfonamide fragment against the hepatitis C virus, conducted by Yili Ding et al. allowed to identify a number of promising antiviral agents [104] . Among the studied 4thiazolidinones the pyrazole derivative 4.66 (Fig. 46) showed moderate effectiveness (IC 50 \u00bc 10 mg/mL and EC 50 \u00bc 70 mg/mL and cytotoxicity index CC 50 \u00bc 90 mg/mL). (SI) > 16.3. In general, tested compounds had no antiviral activity against SARS CoV [97] . The screening was conducted for compounds (Fig. 45) against Trypanosoma brucei brucei (Tbb) and Trypanosoma brucei gambiense (Tbg). The results showed moderate antitrypanosomal activity of compounds 4.67, 4.69 and 4.70 against both strains of tested parasites (activity indexes IC 50 (Tbb) \u00bc 5.43e13.87 mM and IC 50 (Tbg) \u00bc 2.53e6.66 mM) [97] .",
            "cite_spans": [
                {
                    "start": 171,
                    "end": 176,
                    "text": "[104]",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 449,
                    "end": 453,
                    "text": "[97]",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 794,
                    "end": 798,
                    "text": "[97]",
                    "ref_id": "BIBREF96"
                }
            ],
            "ref_spans": [
                {
                    "start": 243,
                    "end": 252,
                    "text": "(Fig. 46)",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 498,
                    "end": 507,
                    "text": "(Fig. 45)",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazoleethiazolidinone hybrids"
        },
        {
            "text": "Aiming to investigate the trypanocidal activity for pyrazolineethiazolidinone conjugates the synthesis of new 5-(pyrazolin-1-ylmethylene)-4-thiazolidinones was carried out (Fig. 48) . Target heterocycles were branched by the methylidene or oxoethylamino-methylidene linker groups. The results of screening against Trypanosoma brucei gambiense allowed to identify 5 compounds with sufficient antitrypanosomal activity (IC 50 1.2 mM) and moderate or low cytotoxicity (CC 50 The study of antiparasitic activity for pyrazolineethiazolidinone 4.76 (Fig. 49 ) was carried out towars Trypanosoma cruzi, Trypanosoma b. rhodesiense, Leishmania donovani and Plasmodium falciparum. The results indicated a moderate inhibitory effect on Trypanosoma b. rhodesiense (IC 50 \u00bc 12 mg/mL) and L. donovani (IC 50 > 30 mg/mL) and a higher influence on P. falciparum (IC 50 > 5 mg/mL) with cytotoxicity index CC 50 > 90 mg/mL [36] .",
            "cite_spans": [
                {
                    "start": 421,
                    "end": 423,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 469,
                    "end": 471,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 905,
                    "end": 909,
                    "text": "[36]",
                    "ref_id": "BIBREF35"
                }
            ],
            "ref_spans": [
                {
                    "start": 172,
                    "end": 181,
                    "text": "(Fig. 48)",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 543,
                    "end": 551,
                    "text": "(Fig. 49",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazoleethiazolidinone hybrids"
        },
        {
            "text": "The promising direction for pharmacological investigation of [105] . Results showed that pyrazolineethiazoles/thiazolidinones 4.79, 4.80 possessed the better anti-inflammatory activity (percentage reduction of paw endema from control group was 17e50, and ketoprofen efficiency e 63%) compared with hexahydroindazole 4.77, 4.78 analogues. Comparing the effectiveness of thiazole derivatives (4.78, 4.80) with thiazolidinones (4.77, 4.79) it could be concluded the higher activity of pyrazolineethiazole hybrids (39e50%) (Fig. 50) .",
            "cite_spans": [
                {
                    "start": 61,
                    "end": 66,
                    "text": "[105]",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 390,
                    "end": 402,
                    "text": "(4.78, 4.80)",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 519,
                    "end": 528,
                    "text": "(Fig. 50)",
                    "ref_id": null
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazoleethiazolidinones"
        },
        {
            "text": "Detailed study of pyrazolineethiazolidinones as potential COX-1 and COX-2 inhibitors allowed to identify highly active compound 4.82 (IC 50 \u00bc 0.5 mM for COX-2) with the best selective index (SI \u00bc 84.8), which effectiveness was similar to that of Celecoxib. SAR analysis (Fig. 51) of the results showed the dependence of COX-2 inhibition on the nature of aryl substituents in the 3 (A-ring) and 5 (B-ring) pyrazoline positions (structure 4.81). Thus, compounds with electron-donor substituents (methyl group) in the para-and meta-positions of the A-ring had better inhibitory effect compared with chlorine. The nature of the substituent in the para-position of the B-cycle also had a significant impact on the inhibitory activity of COX-2 in the order of:",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 270,
                    "end": 279,
                    "text": "(Fig. 51)",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazoleethiazolidinones"
        },
        {
            "text": "To continue the development of structural analogues of Celecoxib, Adnan A. Bekhit et al. synthesized the series of pyrazoleethiazolidines 4.83e4.86 (Fig. 52) for anti-inflammatory activity screening using cotton pellet-induced granuloma and carrageenan-induced rat paw edema bioassays. The highly active compounds were tested for their ability to inhibit COX-1/COX-2 as well as ulcerogenic effect and acute toxicity. The first phase of the study (cotton pellet induced granuloma bioassay) allowed to Structural modification of substituents in the pyrazole moiety allowed to establish the main structural criteria to increase the inhibitory effect [83] .",
            "cite_spans": [
                {
                    "start": 647,
                    "end": 651,
                    "text": "[83]",
                    "ref_id": "BIBREF82"
                }
            ],
            "ref_spans": [
                {
                    "start": 148,
                    "end": 157,
                    "text": "(Fig. 52)",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazoleethiazolidinones"
        },
        {
            "text": "Amal M. Youssef et al. carried out the synthesis of 5-((1,3-aryl-1H-pyrazol-4-yl)methylene)thiazolidine-2,4-diones as potential anti-inflammatory and neuroprotective agents [79] . The studies conducted in vitro and in vivo allowed to identify a group of highly active anti-inflammatory compounds with a low ulcerogenic impact and satisfactory toxicometry parameters. Based on in vitro experiments four compounds (4.89) were selected for in vivo studies according to screening protocols: the formalin-induced paw edema and turpentine oil-induced granuloma pouch bioassays. It was established that the tested compounds showed activity comparable to Celecoxib at a concentration of 20 mg/kg. The introduction of benzyl moiety in position 3 of thiazolidinone was accompanied by the loss of anti-inflammatory activity (Fig. 54 ).",
            "cite_spans": [
                {
                    "start": 173,
                    "end": 177,
                    "text": "[79]",
                    "ref_id": "BIBREF78"
                }
            ],
            "ref_spans": [
                {
                    "start": 813,
                    "end": 821,
                    "text": "(Fig. 54",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazoleethiazolidinones"
        },
        {
            "text": "This review article presents the rational approaches to the design of chemotherapeutic agents based on molecular hybridization of pharmacologically attractive thiazolidine and pyrazole/ pyrazoline heterocycles. Based on linkage of target heterocyclic cores the reviewed hybrids were classified as 2-, 3-and 5-pyrazole/ pyrazoline-substituted thiazolidines. The basic approaches for the synthesis of pyrazole-thiazolidinones have been provided by a combination of two \"small\" molecules via aminolysis, acylation reactions and Knoevenagel procedure or heterocyclization of monocyclic compounds via the [2\u00fe3]-cyclization reaction yielding the series of non-condensed bicyclic systems. The review of biological applications was focused on SAR analysis and mechanistic insights of thiazolidineepyrazole hybrids. Molecular hybridization as a tool of medicinal chemistry has been successfully used for design of biologically active conjugates with antitumor activity, including inhibition of necroptosis, CDC25V phosphatase, TNF-aeTNFRc1 interaction or activation of pro-apoptotic BAX, antimicrobial, antifungal, antiviral and antiparasitic applications, as well as anti-inflammatory properties as inhibitors of COX or ADAMTS-5 enzymes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusions"
        },
        {
            "text": "Abbreviations ADAMTS a disintegrin and metalloproteinase with thrombospondin motifs BAX Bcl-2-associated X protein CC 50 half maximal cytotoxic concentration CDC25V dual-specificity phosphatase, the \"cdc\" in name refers to \"cell division cycle\" DCC dicyclohexylcarbodiimide DTP Development Therapeutics Program EC 50 half maximal effective concentration ED 50 half maximal effective dose IC 50 half maximal inhibitory concentration ",
            "cite_spans": [
                {
                    "start": 118,
                    "end": 120,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 314,
                    "end": 316,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 357,
                    "end": 359,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 391,
                    "end": 393,
                    "text": "50",
                    "ref_id": "BIBREF49"
                }
            ],
            "ref_spans": [],
            "section": "Conclusions"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Advances in the development of hybrid anticancer drugs",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fortin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Berube",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Expert Opin. Drug Discov",
            "volume": "8",
            "issn": "",
            "pages": "1547--1577",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Promise and challenges in drug discovery and development of hybrid anticancer drugs",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "K"
                    ],
                    "last": "Gediya",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "C"
                    ],
                    "last": "Njar",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Expert Opin. Drug Discov",
            "volume": "4",
            "issn": "",
            "pages": "1099--1111",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nepali",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M S"
                    ],
                    "last": "Bedi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Dhar",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Eur. J. Med. Chem",
            "volume": "77",
            "issn": "",
            "pages": "422--487",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Synthesis, biological activity of thiazolidinones bearing indoline moiety and isatin based hybrids",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Mini Rev. Org. Chem",
            "volume": "12",
            "issn": "",
            "pages": "66--87",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "4-Thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Curr. Org. Chem",
            "volume": "8",
            "issn": "",
            "pages": "1547--1577",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Lesyk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Kaminskyy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Kryshchyshyn",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ya",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Atamanyuk",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Subtel&apos;na",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Khyluk",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Biopolym. Cell",
            "volume": "27",
            "issn": "",
            "pages": "107--117",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Rhodanine as a privileged scaffold in drug discovery",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tomasich",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "P"
                    ],
                    "last": "Masich",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr. Med. Chem",
            "volume": "16",
            "issn": "",
            "pages": "1596--1629",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "4-Thiazolidinone -a biologically active scaffold",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Verma",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Saraf",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Eur. J. Med. Chem",
            "volume": "43",
            "issn": "",
            "pages": "897--905",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Chemisry and biological activities of 1,3-thiazolidin-4-ones",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Cunico",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "R B"
                    ],
                    "last": "Gomes",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "T"
                    ],
                    "last": "Vellasco",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Mini Rev. Org. Chem",
            "volume": "5",
            "issn": "",
            "pages": "336--344",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Recent developments and biological activities of thiazolidinone derivatives: a review",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vaidya",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ravichandran",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Kashaw",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem",
            "volume": "20",
            "issn": "",
            "pages": "3378--3395",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "5-Dihydro-1H-pyrazole: an indispensable scaffold",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Ale",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J. Enzyme Inhib. Med. Chem",
            "volume": "4",
            "issn": "",
            "pages": "1547--1577",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Recent advances in the therapeutic applications of pyrazolines",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Shaaban",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Mayhoub",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Farag",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Expert Opin. Ther. Pat",
            "volume": "22",
            "issn": "",
            "pages": "253--291",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Insecticidal lead identification by screening benzopyrano[4,3-c]-pyrazol-3(2H)-ones library constructed from multiple-parallel synthesis under microwave irradiation",
            "authors": [
                {
                    "first": "Z.-Z",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "G.-F",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg. Med. Chem",
            "volume": "14",
            "issn": "",
            "pages": "8666--8674",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Synthesis, fungicidal, and insecticidal activities of b-methoxyacrylate-containing Nacetyl pyrazoline derivatives",
            "authors": [
                {
                    "first": "P.-L",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M.-Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Z.-M",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "G.-F",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J. Agric. Food Chem",
            "volume": "56",
            "issn": "",
            "pages": "10767--10773",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues",
            "authors": [
                {
                    "first": "P.-L",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X.-L",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "C.-G",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "J.-W",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "G.-F",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J. Am. Chem. Soc",
            "volume": "132",
            "issn": "",
            "pages": "185--194",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Unsaturated heterocyclic inhibitors of necroptosis",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Degterev",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "PCT Int. Appl",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "VHR protein tyrosine phosphatase inhibitors, compositions and methods of use",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mustelin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Tautz",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "U.S. Pat. Appl. Publ",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Pin1-modulating compounds and methods of use for the treatment of Pin1-associated diseases, including cancer",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bao",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Kimzey",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "PCT Int. Appl",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Compounds for modulating RNA-binding proteins and uses therefor",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ryder",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "PCT Int. Appl",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Preparation of pyrazol-3-ones as activators of pro-apoptotic BAX",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "D"
                    ],
                    "last": "Walensky",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PCT Int. Appl",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-a",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Carter",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Scherle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Muckelbauer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Voss",
                    "suffix": ""
                },
                {
                    "first": "R.-Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Tebben",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Solomon",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Lo",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Strzemienski",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Falahatpisheh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Farrow",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ramnarayan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rideout",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Yalamoori",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Domaille",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Underwood",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Trzaskos",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Friedman",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Newton",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "P"
                    ],
                    "last": "Decicco",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Proc. Natl. Acad. Sci. U. S. A",
            "volume": "98",
            "issn": "",
            "pages": "11879--11884",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Rhodanine carboxylic acids as novel inhibitors of histoneacetyltransferases",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "Furdas",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shekfeh",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kannan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sippl",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jung",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Commun",
            "volume": "3",
            "issn": "",
            "pages": "305--311",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Design and synthesis of new 4-pyrazolin-3-yl-1,2,3-triazoles and 1,2,3-triazol-4-ylpyrazolin-1-ylthiazoles as potential antimicrobial agents",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "F"
                    ],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Abdel-Latif",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "E A"
                    ],
                    "last": "Awad",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Med. Chem",
            "volume": "52",
            "issn": "",
            "pages": "263--268",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "El-Nassan, Synthesis and antimicrobial activity of some 3,5-diaryl-4,5-dihydropyrazole derivatives",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "El-Enany",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E M"
                    ],
                    "last": "El-Meligie",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Abdou",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "B"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Orient. J. Chem",
            "volume": "26",
            "issn": "",
            "pages": "1265--1270",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Synthesis of new quinoline-2-pyrazolinebased thiazolinone derivatives as potential antimicrobial agents",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Joshi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Rajpara",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res",
            "volume": "22",
            "issn": "",
            "pages": "3663--3674",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Facile synthesis of novel fluorine containing pyrazole based thiazole derivatives and evaluation of antimicrobial activity",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Joshi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Rajpara",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "V"
                    ],
                    "last": "Vaghani",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Satodiya",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Fluor. Chem",
            "volume": "142",
            "issn": "",
            "pages": "67--78",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Synthesis and characterization of some new quinoline based derivatives endowed with broad spectrum antimicrobial potency",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Rajpara",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Joshi",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "22",
            "issn": "",
            "pages": "6871--6875",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of b-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors",
            "authors": [
                {
                    "first": "Y.-S",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "Y.-B",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X.-L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J.-F",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "H.-B",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "H.-L",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "22",
            "issn": "",
            "pages": "4619--4624",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Synthesis and antiviral activity of new pyrazole and thiazole derivatives",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "I"
                    ],
                    "last": "El-Sabbagh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Baraka",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Ibrahim",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pannecouque",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Andrei",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Snoeck",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Rashad",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur. J. Med. Chem",
            "volume": "44",
            "issn": "",
            "pages": "3746--3753",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Synthesis, anticancer and antiviral activity of new 2-pyrazoline substituted 4-thiazolidinones",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J. Heterocycl. Chem",
            "volume": "50",
            "issn": "",
            "pages": "55--62",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Synthesis, biological evaluation and molecular modeling of dihydropyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors",
            "authors": [
                {
                    "first": "K.-M",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xing",
                    "suffix": ""
                },
                {
                    "first": "H.-H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H.-E",
                    "middle": [],
                    "last": "Cui",
                    "suffix": ""
                },
                {
                    "first": "H.-B",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "H.-L",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem",
            "volume": "20",
            "issn": "",
            "pages": "6648--6654",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gzella",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Med. Chem",
            "volume": "55",
            "issn": "",
            "pages": "8630--8641",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zaprutko",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gzella",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur. J. Med. Chem",
            "volume": "44",
            "issn": "",
            "pages": "1396--1404",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "El-Nassan, Synthesis, characterization, and biological evaluation of certain 1,3-thiazolone derivatives bearing pyrazoline moiety as potential anti-breast cancer agents",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Khalil",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "B"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res",
            "volume": "22",
            "issn": "",
            "pages": "1021--1027",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Synthesis and biological evaluation of novel 4,5-dihydropyrazole derivatives as potent anticancer and antimicrobial agents",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "R"
                    ],
                    "last": "Prasad",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "V S"
                    ],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Chandrashekar",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res",
            "volume": "22",
            "issn": "",
            "pages": "2061--2078",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "New 1,3-thiazoles and 1,3-thiazines from 1-thiocarbamoylpyrazoles",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Seebacher",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Belaj",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Saf",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Brun",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Weis",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Monatsh. Chem",
            "volume": "134",
            "issn": "",
            "pages": "1623--1628",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Reaction of acetylenedicarboxylic acids esters with 4,5-dihydro-1H-pyrazole-1-carbothioamides and 3,4,5,6-tetrahydro-2H-1,2,4-triazepine-3-thiones",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Danilkina",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Mikhaylov",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "A"
                    ],
                    "last": "Ivin",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Chem. Heterocycl. Comp",
            "volume": "47",
            "issn": "",
            "pages": "886--900",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "New direction in the reaction of thiocarboxamides with N-substituted maleimides",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "V"
                    ],
                    "last": "Rudenko",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Komykhov",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Desenko",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Chem. Heterocycl. Comp",
            "volume": "45",
            "issn": "",
            "pages": "1017--1018",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual antiinflammatory antimicrobial agents",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T Y"
                    ],
                    "last": "Fahmy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A F"
                    ],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": ".-D",
                    "middle": [
                        "A"
                    ],
                    "last": "Bekhit",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Eur. J. Med. Chem",
            "volume": "45",
            "issn": "",
            "pages": "6027--6038",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Isloor",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sunil",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Shetty",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Malladi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S R"
                    ],
                    "last": "Pai",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Maliyakkl",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res",
            "volume": "22",
            "issn": "",
            "pages": "758--767",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Synthesis of 3-(1-benzyl-1H-benzo[d]imidazol-2-yl amino)-2-(3-aryl-1-phenyl-1H-pyrazol-4-yl)thiazolidin-4-ones and their antimicrobial activities",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Patil",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "M"
                    ],
                    "last": "Goudgaon",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Int. J. Pharm. Sci. Res",
            "volume": "1",
            "issn": "",
            "pages": "50--56",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Synthesis of some new heterocyclic compounds from benzopyrano[2,3-c]pyrazol-3-one derivatives",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Khodairy",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Synth. Commun",
            "volume": "31",
            "issn": "",
            "pages": "2697--2712",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Polyfluoroalkylated 1,3-thiazolines: synthesis from polyfluoro-2,3-epoxyalkanes",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "V"
                    ],
                    "last": "Saloutina",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ya",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "I"
                    ],
                    "last": "Zapevalov",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "I"
                    ],
                    "last": "Kodess",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "G"
                    ],
                    "last": "Saloutin",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "N"
                    ],
                    "last": "Aleksandrov",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Chupakhin",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J. Fluor. Chem",
            "volume": "104",
            "issn": "",
            "pages": "155--165",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Polyfluoro-2,3-epoxyalkanes in reactions with thiourea and thiosemicarbazide",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "V"
                    ],
                    "last": "Saloutina",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ya",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "I"
                    ],
                    "last": "Zapevalov",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "I"
                    ],
                    "last": "Kodess",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "G"
                    ],
                    "last": "Saloutin",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "N"
                    ],
                    "last": "Aleksandrov",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Chupakhin",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Russ. J. Org. Chem",
            "volume": "36",
            "issn": "",
            "pages": "887--899",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Synthesis and antimicrobial activity of novel pyrazolo[3,4-b]quinoline derivatives",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "A"
                    ],
                    "last": "El-Sayed",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Aboul-Enein",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Arch. Pharm. Pharm. Med. Chem",
            "volume": "334",
            "issn": "",
            "pages": "117--120",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Synthesis of thiazole, triazole, pyrazolo[3,4-b]-pyridinyl-3-phenylthiourea, aminopyrazolo[3,4-b]pyridine derivatives and their biological evaluation",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A A"
                    ],
                    "last": "Elneairy",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Attaby",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Elsayed",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem",
            "volume": "167",
            "issn": "",
            "pages": "161--179",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Novel synthesis of pyrazolyloxothiazolidine derivatives",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Hassan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "R"
                    ],
                    "last": "Ibrahim",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "El-Sheref",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Aly",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Braese",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Heterocycl. Chem",
            "volume": "49",
            "issn": "",
            "pages": "1380--1385",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Al-Saadi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A F"
                    ],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T Y"
                    ],
                    "last": "Fahmy",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Med. Chem. Res",
            "volume": "16",
            "issn": "",
            "pages": "300--318",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Synthesis and in vitro antitumor and antimicrobial activity of some 2,3-diaryl-7-methyl-4,5,6,7-tetrahydroindazole and 3,3a,4,5,6,7-hexahydroindazole derivatives",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A F"
                    ],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Asiri",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J. Enzym. Inhib. Med. Chem",
            "volume": "28",
            "issn": "",
            "pages": "495--508",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "3-Methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Al-Saadi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A F"
                    ],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Faidallah",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch. Pharm. Chem. Life Sci",
            "volume": "341",
            "issn": "",
            "pages": "181--190",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Synthesis and in vitro antitumor evaluation of some indeno [1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A F"
                    ],
                    "last": "Rostom",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg. Med. Chem",
            "volume": "14",
            "issn": "",
            "pages": "6475--6485",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Synthesis and biological evaluation of new 3-trifluoromethylpyrazolesulfonyl-urea and thiourea derivatives as antidiabetic and antimicrobial agents",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Asiri",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J. Fluor. Chem",
            "volume": "132",
            "issn": "",
            "pages": "131--137",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Synthesis and biological evaluation of some new bipyrazolylbenzenesulfonamides as possible antimicrobial and chemotherapeutic agents",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Asiri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E M"
                    ],
                    "last": "Zayed",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Indian J. Chem. B",
            "volume": "51",
            "issn": "",
            "pages": "1114--1122",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "An efficient two-step synthesis of novel thiazolo",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tigreros",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Martinez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Quiroga",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Abonia",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gutierrez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nogueras",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cobo",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J. Heterocycl. Chem",
            "volume": "46",
            "issn": "",
            "pages": "756--761",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Synthesis and cytotoxicity screening of some novel benzofuranoyl-pyrazole derivatives against liver and cervix carcinoma cell lines",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "I"
                    ],
                    "last": "El-Zahar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "El-Karim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Anwar",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "S. Afr. J. Chem",
            "volume": "62",
            "issn": "",
            "pages": "189--199",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M A"
                    ],
                    "last": "Ashour",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "S"
                    ],
                    "last": "Ghany",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": ".-D",
                    "middle": [
                        "A"
                    ],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Baraka",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Eur. J. Med. Chem",
            "volume": "43",
            "issn": "",
            "pages": "456--463",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "A convenient route to 1,3,4-thiadiazoles, thiazolidinone, thiazoles, pyridones, coumarins, triazolo[5,1-c]triazines, and pyrazolo[5,1-c] triazines incorporating pyrazolone moiety and their use as antimicrobial agents",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem",
            "volume": "184",
            "issn": "",
            "pages": "2208--2226",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Synthesis, antimicrobial, antioxidant, anti-inflammatory, and analgesic activities of some new 3-(2-thienyl)pyrazole-based heterocycles",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "F"
                    ],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Abdel-Gawad",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "E A"
                    ],
                    "last": "Awad",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Res",
            "volume": "21",
            "issn": "",
            "pages": "1418--1426",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Synthesis and antimicrobial activity of some new heterocycles based on 3-methyl-1-phenyl-5-benzene sulfonamido pyrazole",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "I"
                    ],
                    "last": "El-Emary",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Al-Muaikel",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "S"
                    ],
                    "last": "Moustafa",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem",
            "volume": "177",
            "issn": "",
            "pages": "195--210",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Design and synthesis of some oxadiazolyl, thiadiazolyl, thiazolidinyl, and thiazolyl derivatives of 1H-pyrazole as antiinflammatory antimicrobial agents",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Farghaly",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arch. Pharm. Pharm. Med. Chem",
            "volume": "333",
            "issn": "",
            "pages": "53--57",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "New pyrazole derivatives of potential biological activity",
            "authors": [
                {
                    "first": "A.-R",
                    "middle": [],
                    "last": "Farghaly",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Esmail",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abdel-Hafez",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Vanelle",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "El-Kashef",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "228--241",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Convenient synthesis and antimicrobial activity of new 3-substituted 5-(benzofuran-2-yl)-pyrazole derivatives",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "F"
                    ],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Abdel-Aziz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Ahmed",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch. Pharm. Chem. Life Sci",
            "volume": "341",
            "issn": "",
            "pages": "734--739",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Cytotoxicity and utility of 1-indanone in the synthesis of some new heterocycles",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hegazi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Dawood",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": ".-R",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Chem. Pharm. Bull",
            "volume": "58",
            "issn": "",
            "pages": "479--483",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Synthesis, anti-HSV-1, and cytotoxic activities of some new pyrazole-and isoxazole-based heterocycles",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Dawood",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Abdel-Gawad",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Med. Chem. Res",
            "volume": "20",
            "issn": "",
            "pages": "912--919",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "The use of 3-amino-4,6-dimethylpyrazolo[3,4-b]pyridine in the synthesis of novel heterocycles of pharmaceutical interest",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Metwally",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Etman",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "E"
                    ],
                    "last": "Gafer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Khalil",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Chem. Heterocycl. Compd",
            "volume": "44",
            "issn": "",
            "pages": "715--721",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Reaction of 3-phenyl-5-aminopyrazole with carbon disulfide: a novel synthesis of 3-(3 0 -phenylpyrazol-5'-yl)-4-phenylpyrazol-2-thione as well as of pyrazolo",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Mohareb",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "F"
                    ],
                    "last": "Zohdi",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Wardakhan",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Monatsh. Chem",
            "volume": "126",
            "issn": "",
            "pages": "1391--1400",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Synthesis and antitumor activity of some novel pyrazole and thienopyrimidine derivatives",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Aly",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem",
            "volume": "185",
            "issn": "",
            "pages": "211--221",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M A"
                    ],
                    "last": "Ashour",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E A"
                    ],
                    "last": "Wahab",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Arch. Pharm. Chem. Life Sci",
            "volume": "342",
            "issn": "",
            "pages": "238--252",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Synthesis and biological activity of 4 0 -oxathiazolidinyl benzopyrazoles",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "P"
                    ],
                    "last": "Shetgiri",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Chitre",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Kokitkar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Ghate",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Patil",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Kelaskar",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "",
            "volume": "45",
            "issn": "",
            "pages": "1308--1311",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Pathak",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "T"
                    ],
                    "last": "Chovatia",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Parekh",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "22",
            "issn": "",
            "pages": "5129--5133",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Rac-3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-phenylthiazolidin-4-one: sheets built from N-H\u2026N and C-H\u2026pi(arene) hydrogen bonds",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "N"
                    ],
                    "last": "Low",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cobo",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Orozco",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Glidewell",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Acta Crystallogr. C",
            "volume": "60",
            "issn": "",
            "pages": "486--488",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Synthesis and antimicrobial study of linked heterocyclics containing pyrazole-pyrimidine-thiazolidin-4-one",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "V"
                    ],
                    "last": "Devi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sunitha",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nagaraj",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Chem. Pharm. Bull",
            "volume": "58",
            "issn": "",
            "pages": "1622--1626",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Novel fluorinated spiro [indole-indazolyl-thiazolidine]-2,4 0 -diones: design and synthesis, Phosphorus Sulfur Silicon Relat",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bhagat",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sakhuja",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Elem",
            "volume": "180",
            "issn": "",
            "pages": "1829--1839",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Synthesis and pharmacological studies of some phthalimidoxy substituted spirothiazolidinone derivatives of isatin",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bhambi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "K"
                    ],
                    "last": "Salvi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Talesara",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Indian J. Chem. B",
            "volume": "48",
            "issn": "",
            "pages": "1006--1012",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Synthese substituierter rhodanine",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Augustin",
                    "suffix": ""
                },
                {
                    "first": "W.-D",
                    "middle": [],
                    "last": "Rudorf",
                    "suffix": ""
                }
            ],
            "year": 1974,
            "venue": "J. Prakt. Chem",
            "volume": "316",
            "issn": "",
            "pages": "520--524",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Synthesis and in vivo anticancer and antiangiogenic effects of novel thioxothiazolidin-4-one derivatives against transplantable mouse tumor",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chandrappa",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chandru",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sharada",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Vinaya",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S A"
                    ],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Thimmegowda",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Nagegowda",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Rangappa",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Med. Chem. Res",
            "volume": "19",
            "issn": "",
            "pages": "236--249",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Synthesis of new 4-azolidinones with 3,5-diaryl-4,5-dihydropyrazole moiety and evaluation of their antitumor activity in vitro",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kovach",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Ann. Univ. Mariae Curie-Sklodowska",
            "volume": "23",
            "issn": "",
            "pages": "173--177",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Dicationic ionic liquid mediated synthesis of 5-arylidine-2,4-thiazolidinediones",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Jawale",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Lingampalle",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Mane",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "R"
                    ],
                    "last": "Pratap",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Chin. J. Chem",
            "volume": "29",
            "issn": "",
            "pages": "942--946",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Youssef",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "B"
                    ],
                    "last": "Villanueva",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "El-Ashmawy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Klegeris",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Bioorg. Med. Chem",
            "volume": "18",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Synthesis and antimicrobial activity of some new of 5-((3-(aryl)-1-phenyl-1H-pyrazol-4-yl) methylene)-3-phenylthiazolidine-2,4-diones",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Prakash",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Aneja",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Aneja",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Res",
            "volume": "21",
            "issn": "",
            "pages": "10--15",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Synthesis and antimicrobial activity of 5-((3-aryl-1-phenyl-1H-pyrazol-4-yl) methylene)thiazolidine-2,4-diones",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Prakash",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Aneja",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lohan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hussain",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Aneja",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Res",
            "volume": "21",
            "issn": "",
            "pages": "2961--2968",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Insuasty, Synthesis, antifungal and antitumor activity of novel (Z)-5-hetarylmethylidene-1,3-thiazol-4-ones and (Z)-5-ethylidene-1,3-thiazol-4-ones",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ramirez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Raimondi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Echeverry",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Quiroga",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Abonia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nogueras",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cobo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "V"
                    ],
                    "last": "Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Zacchino",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Molecules",
            "volume": "18",
            "issn": "",
            "pages": "5482--5497",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "1H-Pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Gilbert",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Bursavich",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lombardi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Georgiadis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Reifenberg",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Flannery",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Morris",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "17",
            "issn": "",
            "pages": "1189--1192",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Synthesis and antimicrobial activity of some new N-glycosides of 2-thioxo-4-thiazolidinone derivatives",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Metwally",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Abdalla",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A N"
                    ],
                    "last": "Mosselhi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "El-Desoky",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Carbohydr. Res",
            "volume": "345",
            "issn": "",
            "pages": "1135--1141",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents",
            "authors": [
                {
                    "first": "C.-J",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "M.-X",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "L.-P",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "H.-R",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "22",
            "issn": "",
            "pages": "7024--7028",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Synthesis and antibacterial activity of novel 1,3-diphenyl-1H-pyrazoles functionalized with phenylalanine-derived rhodanines",
            "authors": [
                {
                    "first": "C.-J",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "L.-L",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L.-P",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "H.-R",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Med. Chem",
            "volume": "58",
            "issn": "",
            "pages": "112--116",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Structure-activity relationship study of a novel necroptosis inhibitor",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Degterev",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Hsu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "",
            "volume": "18",
            "issn": "",
            "pages": "4932--4935",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Synthesis and antimicrobial evaluation of some novel 2-(4-chlorophenylimino)thiazolidin-4-one derivatives",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bhatt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J. Korean Chem. Soc",
            "volume": "56",
            "issn": "",
            "pages": "341--347",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "F"
                    ],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "E A"
                    ],
                    "last": "Awad",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Eur. J. Med. Chem",
            "volume": "46",
            "issn": "",
            "pages": "1505--1511",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Studies on 2-pyrazolin-5-one derivatives",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mitra",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nayak",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Mittra",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "J. Indian Chem. Soc",
            "volume": "59",
            "issn": "",
            "pages": "1005--1007",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kovach",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Arch. Pharm. Chem. Life Sci",
            "volume": "344",
            "issn": "",
            "pages": "514--522",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Synthesis and biological activity of 4-(3-aryl-4-oxo-2-thioxothiazolidin-5-ylimino)-3-methyl-1-(N,N-disubstituted aminomethyl) pyrazolin-5-ones",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "I"
                    ],
                    "last": "Husain",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shukla",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Indian J. Chem",
            "volume": "25",
            "issn": "",
            "pages": "983--985",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "A new approach for the synthesis of bioactive heteroaryl thiazolidine-2,4-diones",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Ibrahim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": ".-M. Abdel-Hamed",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "M"
                    ],
                    "last": "El-Gohary",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J. Braz. Chem. Soc",
            "volume": "22",
            "issn": "",
            "pages": "1130--1139",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Preparation of fused ring compounds for treatment of diabetes",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tawaraishi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Imoto",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Syntheis and fungitoxicity of some bicyclic compounds",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mittra",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Mittra",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "J. Indian Chem. Soc",
            "volume": "58",
            "issn": "",
            "pages": "923--925",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Day",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "Smee",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Grellier",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur. J. Med. Chem",
            "volume": "66",
            "issn": "",
            "pages": "228--237",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Karpenko",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Grellier",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Eur. J. Med. Chem",
            "volume": "85",
            "issn": "",
            "pages": "245--254",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sarkis",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "N"
                    ],
                    "last": "Tran",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Miteva",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kolb",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "O"
                    ],
                    "last": "Villoutreix",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Garbay",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Braud",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "22",
            "issn": "",
            "pages": "7345--7350",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Synthesis of novel linked pyrazolyl-thiazolidinone heterocycles as potent antibacterial agents",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "R"
                    ],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "V"
                    ],
                    "last": "Devi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nagaraj",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Acta Chim. Slov",
            "volume": "58",
            "issn": "",
            "pages": "576--581",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Design and synthesis of spiro",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sakhuja",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Panda",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Khurana",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Jain",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "21",
            "issn": "",
            "pages": "5465--5469",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinoloneresistant Staphylococcus aureus (MRSA and QRSA)",
            "authors": [
                {
                    "first": "M.-X",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "C.-J",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "X.-Q",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                },
                {
                    "first": "L.-P",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "Y.-J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z.-Y",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "M.-J",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "H.-R",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur. J. Med. Chem",
            "volume": "60",
            "issn": "",
            "pages": "376--385",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents",
            "authors": [
                {
                    "first": "L.-L",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "C.-J",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "L.-P",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "H.-R",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Med. Chem",
            "volume": "48",
            "issn": "",
            "pages": "174--178",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "V N S"
                    ],
                    "last": "Varaprasad",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Alexander",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "17",
            "issn": "",
            "pages": "841--845",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "N A"
                    ],
                    "last": "Nasr",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Said",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Arch. Pharm. Pharm. Med. Chem",
            "volume": "336",
            "issn": "",
            "pages": "551--559",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF1": {
            "text": "Heterocycles for pyrazole/pyrazolineethiazole/thiazolidine hybridization and the most promising conjugates.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Three-component one-pot reactions in synthesis of 2-pyrazolinyl-4-thiazolidinones. Thioglycolic acid reagent in thiazolidinone ring-formation reactions.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "bromoacetate[66]. The presence of the methylene group in the position 5 of thiazolidine cycle allowed the authors to carry out the structural modification of pyrazoleethiazolidinone 2.3 in the Knoevenagel reaction (ethanol medium, catalyst e piperidine) and diazotization to get the 5-substituted derivatives 2.4, 2.5. Starting from rhodanine 2.3 the alternative methods for the synthesis of condensed pyrano[2,3-d]thiazole system 2.6 with pyrazole moiety in position 3 were proposed, namely the reaction of 5arylidenerhodanines 2.5 with malononitrile or by heterocyclization of compound 2.3 with benzylidenemalononitrile. Pyrazoleethiazolidinone 2.3 in the presence of hydrazine hydrate undergoes ring transfomation with obtaining of the pyrazole-triazole 2.7(Fig. 12).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Example of pyrazole formation in the synthesis of pyrazole-thiazolines. Synthesis of pyrazoleethiazolidinones with imine linker group. Synthesis of diazoleethiazolidinones/thiazolidines with sulfonylimine linker group. Aminolysis reaction in synthesis of pyrazoleethiazolidinones.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5One of the main approaches for the synthesis of 5-pyrazole/ pyrazoline substituted 4-thiazolidinones is based on Knoevenagel reaction of 4-thiazolidinones[5]. A numerous 1-, 3-and 5substituted pyrazole-4-carbaldehydes were used as carbonyl compounds and allowed to obtain a series of new 2,4thiazolidinediones [78e81], rhodanines [82e86] and 2-imino-4thiazolidinones with pyrazole moiety (compounds 3.1) [87e89]. The synthesis of pyrazoloneethiazolidinones 3.2 was conducted by reaction of 3-arylrhodanines with 4-acetyl-5-methyl-2-phenyl-2,4dihydropyrazol-3-one[90]. Position 5 of thiazolidine cycle was",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Synthesis of pyrazole derivatives with thiazolidinone, imidazolidine and thiazoline fragments in molecules.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "Pyrazole-substituted thiosemicarbazides in synthesis of pyrazoleethiazole hybrids. Synthesis of 3-diazole-substituted 4-thiazolidinones.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "Ahmed Ibrahim et al. investigated a modification of 5-[4oxo-4H-chromen-3-yl)methylene]-1,3-thiazolidin-2,4-dione 3.8, in particular in the ring-transformation reactions of chromene cycle with hydrazine hydrate and phenylhydrazine. Synthesis and modification of 3-pyrazole-substituted rhodanines.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "a-Mercaptocarboxylic acids reagent in the synthesis of 3-subtituted thiazolidinones.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "Holmberg synthesis for benzopyrazoleerhodanine.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "Synthesis of pyrazoleethiazolidinone conjugates via acylation reaction. Synthesis of pyrazolineeazolidinone conjugates via alkylation reaction. Knoevenagel and diazo coupling reactions for synthesis of pyrazoleethiazolidinones. Synthesis of pyrazolineeindolineethiazolidinone conjugates.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "Fig. 21). Pharmacologically attractive 5-(5-oxo-4,5-dihydro-1H-pyrazol-4-yl)rhodanines 3.12 (Fig. 22) were synthesized following heterocyclization of 2-thiazolidinyl-3-oxobutanoates with phenylhydrazine or conjugation of 4-bromopyrazolon-5-ones to 3arylrhodanines [96]. The group of pyrazolineethiazolidinones 3.13 was obtained by reaction of 5-bromo-2,4-thiazolidindione with 3,5diarylpyrazolines in alcohol medium (Fig. 23). The synthesized compounds were modified in position 3 of thiazolidine cycle by Mannich reaction with secondary cyclic amines and alkylation reactions forming 3.14, 3.15 [97]. The following approach to the synthesis of pyrazolineethiazolidinone conjugates 3.16 with carbonyl methylidene linker group was based on the acylation reaction of 3,5diarylpyrazolines (Fig. 24). The further reaction of substances 3.16 with chloroacetamides via N-alkylation reaction led to derivatives 3.17 [97]. To explore the structure-antitrypanosomal activity relationship the pyrazolineethiazolidinone conjugates 3.18 were synthesized through the reaction of the 5-ethoxymethylidenerhodanines with 3,5-diarylpyrazolines (Fig. 25). 5-Pyrazoline substituted 4-thioxo-2-thiazolidinones 3.19 were obtained under the same conditions [98]. To continue the above mentioned study, 5-pyrazoline derivatives of 4-thiazolidinone 3.21 with oxoethylamino-methylene linker group were synthesized by modification of rhodanine-5carboxylic acid 3.20 in the reaction with pyrazolines and in the presence of DCC (dicyclohexylcarbodiimide) [98] (Fig. 26).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "and TGI values of 0.071 mM and 0.76 mM, respectively and demonstrated the highest antiproliferative influence on the non-small cell lung cancer cell line HOP-92 (GI 50 < 0.01 mM), colon cancer line HCT-116 (GI 50 \u00bc 0.018 mM), CNS cancer cell line SNB-75 (GI 50 \u00bc 0.0159 mM), ovarian cancer cell line NCI/ADR-RES (GI 50 \u00bc 0.0169 mM) and renal cancer cell line RXF 393 (GI 50 \u00bc 0.0197 mM). The SAR study revealed that: (1) potent anticancer activity of tested compounds depended on the presence of a combination of three heterocycles in one molecule, thus the pyrazolineethiazolidinoneeisatin conjugates were more active in comparison with pyrazolineethiazolidinone or pyrazole-indoline-2-one systems;",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "Chromene ring-transformation reactions in synthesis of thiazolidinoneediazole hybrids. Y. Rajendra Prasad et al. synthesized a series of pyrazolineethiazoles 4.7, 4.8, and examined their antitumor activity in vitro on tumor lines: Hela (human cervix carcinoma cell line), A549 (human lung adenocarcinoma cell line), MCF-7 (human breast adenocarcinoma cell line), A2780 (human ovarian cancer cell line) and BGC-823 (human gastric cancer cell line),",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "Alternative approaches for the synthesis of thiazolidinoneepyrazolones. Synthesis and modification of pyrazolineethiazolidinones. Synthesis and alkylation of thiazolidinoneepyrazolines 3.16. 18. X = O, Y = S, R = Alk, Ar 3.19. X = S, Y = O, R = H EtOH Fig. 25. Synthesis of 5-pyrazoline substituted thiazolidinones.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "Synthesis of pyrazolineerhodanine conjugates with oxoethylamino-methylene linker group.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "Antitumor activity for pyrazolineethiazolidinone based hybrids.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF18": {
            "text": "Isatin-based conjugates with antitumor activity. concentration [48e51].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF19": {
            "text": "activity index of 10.6 mM. Further studies aiming to optimize of Nec-7 molecule, were focused on the modification of thiazole fragment, replacement of substituents in the phenyl ring and replacement of pyrazole cycle by other heterocycles. It was established that the replacement of thiazole fragment by the 1,3,4-thiadiazole led to the complete loss of activity. The introduction of the methyl group in Hela) = 4.23 \u03bcM IC 50 (A549) = 0.96 \u03bcM IC 50 (MCF-7) = 1.20 \u03bcM IC 50 (Hela) = 4.86 \u03bcM IC 50 (A549) = 1.21 \u03bcM IC 50 (BGC-823) = 1.20 \u03bcM Thiazoleepyrazoline hybrids with antitumor activity. 14 GI 50 = 46.8 \u03bcM 4.15 R = phenyl GI 50 = 54.9 \u03bcM 4.16 R = benzoyl GI 50 = 42.6 \u03bcM 4.18 GI 50 = 20.04 \u03bcM 4.17 GI 50 = 44.7 \u03bcM 4.12 GI 50 = 30.2 \u03bcM 4.13 GI 50 = 41.7 \u03bcM Pyrazoline-thiazolidinones Pyrazoline-thiazolidines Antitumor thiazolidinone/thiazole derivatives with pyrazoline moiety in 2 position. the 4 position of thiazole caused a slight gain of inhibitory action, while presence of methyl in the 5 position of thiazole had a negative effect. The most effective direction for modification of Nec-7 was the replacement of fluorine atom in the 4 position of benzene core. Thus, the introduction of morpholine (4.22)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF20": {
            "text": "substituted 4-thiazolidinones (compounds 4.27 and 4.28) was carried out within the DTP NCI [77,97]. 19 GI 50 = 5.0 \u03bcg/ml (HEPG2) 4.20 GI 50 = 1.2 \u03bcg/ml (HEL A) Antitumor azolidine-pyrazolines with thiazolidinone/thiazole fragments. Antitumor activity of pyrazole-thiazolidinoneetriazoles on lung cancer. 50 = 10.6 \u03bcM 4.22 EC 50 = 2.93 \u03bcM 4.23 EC 50 = 1.29 \u03bcM 4.24 EC 50 = 1.78 \u03bcM Essential heterocyclic cores para-position is optimal Fig. 33. 5-Pyrazoline-substituted pseudothiohydantoines as promising necroptosis inhibitors. had a moderate activity, but two compounds were identified with selective effect on leukemia cell lines with effective concentration GI 50 2.12e4.58 mM (4.29) and 1.64e3.20 mM (4.30). SAR analysis",
            "latex": null,
            "type": "figure"
        },
        "FIGREF21": {
            "text": "Abdel-Wahab et al. was more successful. The authors synthesized a group of triazoleepyrazolineethiazoles and corresponding 4thiazolidinones and studied their activity against gram-positive bacteria (S. aureus ATCC 29213, B. subtilis ATCC6633, Bacillus megaterium ATCC 9885, Sarcina lutea), gram-negative bacteria (Klebseilla pneumonia ATCC13883, P. aeruginosa ATCC27953, E. coli ATCC 25922) and fungi (Saccharomyces cerevisiae and C. albicans NRRL Y-477) compared with Ciprofloxacin and Ketoconazole[23]. Among the tested thiazoleepyrazolines compound 4.33 showed the highest activity for strain P. aeruginosa (MIC \u00bc 8.25 mg/mL), which was twice higher than for Ciprofloxacin. Activity of 4.34 appeared commensurate with the drug for bacteria S. aureus and B. subtilis(MIC \u00bc 8.25 mg/mL). At the same time 4.35 showed a high antifungal activity (MIC \u00bc 8.25 mg/mL). It should be noted that the replacement of thiazole fragment with the 4-thiazolidinone was accompanied by the loss of antimicrobial activity against most types of bacteria and fungi, but compound 4.36 showed the highest activity in B. megaterium and E. coli, which were much less sensitive to the action of thiazoleepyrazolines (Fig. 37). Study of antimicrobial activity for structurally related quinolineepyrazolineethiazolidones 4.37 against strains E. coli (MTCC 443), P. aeruginosa (MTCC 1688), S. aureus (MTCC 96), Streptococcus pyogenes (MTCC 442) and antifungal effect on C. albicans (MTCC CEM (Leukemia) GI 50 = 2.50 \u03bcM RPMI-8226 (Leukemia) GI 50 = 2.52 \u03bcM EKVX (Non-Small Cell Lung Cancer) GI 50 = 3.03 \u03bcM, NCI-H522 (Non-Small Cell Lung Cancer) GI 50 = 2.96 \u03bcM HOP-92 (Non-Small Cell Lung Cancer) GI 50 = 0.62 \u03bcM 4.Selective antitumor activity of pyrazole-rhodanine 4.25.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF22": {
            "text": "Bis-thiazolone with indazole fragment as potential inhibitor of CDC25V phosphatase. 29 GI 50 = 2.12 -4.58 \u03bcM 4.30 GI 50 = 1.64 -3.20 \u03bcM Antitumor activity of 4-thiazolidinones with pyrazolines in 5 position. 227), Aspergillus niger (MTCC 282) and Aspergillus clavatus (MTCC 1323) evidenced of their minor or moderate activity on most types",
            "latex": null,
            "type": "figure"
        },
        "FIGREF23": {
            "text": "Adnan A. Bekhit et al. synthesized the pyrazolineethiazoles and thiazolidinones with sulfanilamide group. Among the studied pyrazolethiazolidinones 4.43 and pyrazoleethiazoles 4.44 the compounds 4.43b (R \u00bc Me) and 4.44a (R \u00bc H) (Fig. 39) were most effective against E. coli (MIC \u00bc 25 mg/mL) [56]. The study of wide range of antimicrobial and antifungal activities of new benzofuranylepyrazoles with thiazolidinone fragment was conducted by Bakr F. Abdel-Wahab et al. The compound 4.45 showed activity against C. albicans and B. subitilis, and thiazolederivative 4.46 was effective against the E. coli [62] (Fig. 40). To continue the research of pyrazole derivatives with different heterocycles, authors conducted the synthesis of new derivatives of pyrazole with thiophene fragment 4.47e4.49, including pyrazolethiazolidine 4.50 (Fig. 40) and offered a wide range of biological studies, including the evaluation of antimicrobial activity against the following microorganisms: S. aureus ATCC 29213, B. subtilis ATCC6633, Salmonella typhi, Enterobacter Cloaca ATCC3047, K. peneumoniae ATCC13883, P. aeroginosa ATCC27953, E. coli ATCC 25922, Enterococcus faecalis ATCC29212, Mycobacterium phlei, S. cervesiae and C. albicans NRRL Y-477. Among the tested compounds 4.47 and 4.49 showed hihg/good or moderate efficiency against all strains of microorganisms. While compound 4.48 had proved to be the most effective on E. faecalis (MIC \u00bc 83.3 mg/mL), compound 4.50",
            "latex": null,
            "type": "figure"
        },
        "FIGREF24": {
            "text": "Pyrazolineethiazolidinone hybrids with antimicrobial activity. SAR analysis of antimicrobial pyrazoleethiazolidinone hybrids. antimicrobial (B. subtilis MTCC 441, Bacillus sphaericus MTCC 11, S. aureus MTCC 96, P. aeruginosa MTCC 741, Klobsinella aerogenes MTCC 39 and Chromobacterium violaceum MTCC 2625) and antifungal (C. albicans ATCC 10231, Aspergillus fumigatus HIC 6094, Trichophyton rubrum IFO 9185 and Trichophyton mentagrophytes IFO 40996) activities. Despite the wide range of antimicrobial research, none of the tested compounds was more active than Penicillin (MIC \u00bc 1.56e12.5 mg/mL). The range value of the minimum inhibitory concentration was 13e30 mg/mL. However, it should be noted an antifungal activity of pyrazole-pyrimidineethiazolidinones 4.56.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF25": {
            "text": "Antimicrobial and antifungal pyrazoleethiazolidinones/thiazoles, coupled by hydrazone linker group. Antimicrobial and antifungal activity for polyheterocyclic systems based on pyrazole-thiazolidinones/thiazoles.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF26": {
            "text": "Antimicrobial thiazolidines/thiazoles with 5-pyrazolone fragment.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF27": {
            "text": "Pyrazoline substituted 4-thiazolidinones (Fig. 47) were studied for their antiviral activity against SARS coronavirus (SARS CoV) and influenza types A and B viruses (Flu A, Flu B), as well as antitrypanosomal effect against Trypanosoma brucei brucei (Tbb) and Trypanosoma brucei gambiense (Tbg). Overall compounds were characterized by the similar values of anti-influenza viruses' activity and cytotoxicity with selectivity indexes 1.0 to 2.1. Compound 4.68 had moderate activity against duck strain of influenza A with 50% effective concentration (EC 50 ) 21.78 mM and selectivity index Pyrazole-pyrimidineethiazolidinones as promising antimicrobial agents.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF28": {
            "text": "Antimicrobial activity of 4-thiazolidinones with pyrazole in 5 position.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF29": {
            "text": "\u00bc 13.6 -> 184.3 mM) towards myoblast derived cell line (L-6). Compounds 4.71 (IC 50 \u00bc 0.6 mM, CC 50 \u00bc 175.2 mM, SI \u00bc 292) and 4.72 (IC 50 \u00bc 0.7 mM, CC 50 \u00bc 40 mM, SI \u00bc 57) were significantly more effective than Nifurtimox (IC 50 \u00bc 4.4 mM, 78.2 mM \u00bc CC 50 , SI \u00bc 17.8). SAR analysis has been directed on substitution of pyrazoline core and modification of N3-thiazolidinone position (4.73), elongation of linker group (4.74) and rhodanine-isorhodanine isomerism (4.75) [98].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF30": {
            "text": "Structure-antimicrobial activity relationship for pyrazoleerhodanine derivatives. Pyrazole/pyrazolinesethiazolidinone/thiazoles with antiviral activity. 68 R = OMe, Ar = 4-Me-C 6 H 4 ; 4.69 R = Cl, Ar = 4-Me-C 6 H 4 ; 4.70 R = Cl, Ar = 4-OMe-C 6 H 4 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF31": {
            "text": "Antiviral and antitrypanosomal 5-pyrazoline substituted 4-thiazolidinones. pyrazoleethiazolidinones is the search for new anti-inflammatory agents considering their structural relationship with a known NSAIDs COX-2 inhibitor e celecoxib. Magda N.A. Nasr and Shehta A. Said studied a group of pyrazolineethiazolidine/thiazoles 4.79, 4.80 and thiazolidine/thiazole derivatives with hexahydroindazole fragment 4.77, 4.78 and carried out in vivo research on carrageenin induced paw edema at dose of 100 mg/kg using ketoprofen as a reference standard",
            "latex": null,
            "type": "figure"
        },
        "FIGREF32": {
            "text": "SAR for trypanocidal 5-(pyrazolin-1-ylmethylene)-4-thiazolidinones. Pyrazolineethiazolidinone hybrid with antiparasitic activity. Thiazolidinones and thiazoles with pyrazoline fragments as anti-inflammatory agents. compound (IC 50 = 0.5 \u03bcM for COX-2, SI = 84.8) Electron-donating substituents at paraand meta-positions Pyrazolineethiazolidinone hybrids as COX-2 inhibitors. establish that all compounds possessed anti-inflammatory activity with ED 50 \u00bc 7.86e28.42 mM and the thiazolidine carboxylic acid derivatives (compounds 4.83 e ED 50 \u00bc 9.74e11.86 mM, compounds 4.84 e ED 50 \u00bc 7.86e8.11 mM) showed better efficiency than Celecoxib (ED 50 \u00bc 16.74 mM) and commensurable with Indomethacin (ED 50 \u00bc 9.64 mM). Further studies of highly active compounds (4.83 and 4.84) allowed to identify their ability to selective inhibition of COX 2 (IC 50 \u00bc 0.38e0.94 mM) and reaffirmed their low ulcerogenic action and acute toxicity [39]. Adam M. Gilbert et al. synthesized a series of 5pyrazolylmethylidene-2-thioxo-4-thiazolidinones 4.87 (Fig. 53) as potential inhibitors of ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) with significant antiinflammatory activity. Highly active compound 4.88 was identified with the inhibition of ADAMTS-5 IC 50 \u00bc 1.1 mM, that demonstrated a strong selectivity (SI > 40) compared to the inhibition of ADAMTS-4.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF33": {
            "text": "Pyrazole-thiazolidine hybrids as COX-2 inhibitors. Pyrazoleethiazolidinones with anti-inflammatory activity.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Fig. 2. Synthesis of pyrazolineethiazolidinones via [2\u00fe3]-cyclization reactions.",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "drug concentration resulting in a 50% reduction in the net protein increase in control cells during the drug TNFRc1 type-1 tumor necrosis factor receptor VHR Vaccinia virus H1 Related e a dual-specificity phosphatase",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}